Semaglutide is a peptide known as a glucagon-like peptide 1 (GLP1)
GLP1 can prompt the body to produce more insulin in response to eating, which reduces blood glucose levels. Â Semaglutide is researched for the chronic metabolic disease of obesity by interacting with the part of the brain that suppresses appetite and signals fullness. Â Research has shown that with a reduction in obesity there can be a reduced risk of cancer, diabetes and heart disease.
*Reconstitute lyophilized powder with Bacteriostatic water* *NOT INCLUDED. MUST BE ORDERED SEPARATELY*
